Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy

Published:2019-05-30 Issue:3 Volume:60 Page:512-520
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Ge Zhi-Dong¹²,Lian Qingquan¹,Mao Xiaowen¹,Xia Zhengyuan¹³

Affiliation:

1. Department of Anesthesiology, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou

2. Department of Anesthesiology, Medical College of Wisconsin, Milwaukee

3. Department of Anesthesiology, The University of Hong Kong

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/60/3/60_18-476/_pdf

Reference108 articles.

1. 1. Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol 2018; 71: 339-51.

2. 2. Pant T, Dhanasekaran A, Fang J, et al. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord 2018; 18: 197.

3. 3. Ohno S, Kohjitani A, Miyata M, et al. Recovery of endothelial function after minor-to-moderate surgery is impaired by diabetes mellitus, obesity, hyperuricemia and sevoflurane-based anesthesia. Int Heart J 2018; 59: 559-65.

4. 4. Baumgardt SL, Paterson M, Leucker TM, et al. Chronic co-administration of sepiapterin and L-citrulline ameliorates diabetic cardiomyopathy and myocardial ischemia/reperfusion injury in obese type 2 diabetic mice. Circ Heart Fail 2016; 9: e002424.

5. 5. Wu HE, Baumgardt SL, Fang J, et al. Cardiomyocyte GTP cyclohydrolase 1 protects the heart against diabetic cardiomyopathy. Sci Rep 2016; 6: 27925.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective Effects of Exercise: The Role of Irisin and Exosome;Current Vascular Pharmacology;2024-09

2. Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases;Journal of Drug Targeting;2024-05-24

3. E1231 Alleviates Diabetic Cardiomyopathy by Regulating the Silent Information Regulator 1/Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α/Nuclear Factor Erythroid 2-Related Factor 2 Pathway;Pharmaceutical Chemistry Journal;2024-05

4. Mechanistic Insights and Potential Therapeutic Implications of NRF2 in Diabetic Encephalopathy;Molecular Neurobiology;2024-03-14

5. Lipoamide Attenuates Hypertensive Myocardial Hypertrophy Through PI3K/Akt-Mediated Nrf2 Signaling Pathway;Journal of Cardiovascular Translational Research;2024-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3